Personal information

Activities

Employment (4)

Xavier University of Louisiana: New Orleans, Louisiana, US

2024-04 to present | Professor (Pharmaceutical Sciences)
Employment
Source: Self-asserted source
Rami Al-Horani

Xavier University of Louisiana: New Orleans, LA, US

2020 to 2024-03 | Associate Professor (Division of Pharmaceutical Sciences)
Employment
Source: Self-asserted source
Rami Al-Horani

Xavier University of Louisiana: New Orleans, LA, US

2016 to 2020 | Assistant Professor (Division of Pharmaceutical Sciences)
Employment
Source: Self-asserted source
Rami Al-Horani

Virginia Commonwealth University: Richmond, VA, US

2012 to 2016 | Senior Research Scientist and Postdoctoral Fellow (Department of Medicinal Chemistry & Institute for Structural Biology, Drug Discovery and Development)
Employment
Source: Self-asserted source
Rami Al-Horani

Education and qualifications (4)

Texas A&M University: College Station, Texas, US

2023-03 to 2023-04 | Advanced Certificate in Biopharmaceutical Manufacturing (National Center for Therapeutic Manufacturing)
Education
Source: Self-asserted source
Rami Al-Horani

Virginia Commonwealth University: Richmond, VA, US

2007 to 2012 | Ph.D. (Medicinal Chemistry)
Education
Source: Self-asserted source
Rami Al-Horani

University of Jordan: Amman, JO

2000 to 2003 | M.Sc. (Pharmaceutical Sciences)
Education
Source: Self-asserted source
Rami Al-Horani

University of Jordan: Amman, JO

1995 to 2000 | B. Pharm. (Pharmacy)
Education
Source: Self-asserted source
Rami Al-Horani

Funding (3)

Inhibitors of Human Factor XIIIa as New Anticoagulants

2023-04 to 2027-03 | Grant
National Institute of General Medical Sciences (Bethesda, Maryland, US)
GRANT_NUMBER:

R16GM149412

Source: Self-asserted source
Rami Al-Horani

Inhibitors of the Intrinsic Pathway of Coagulation as New Anticoagulants

2019-04-01 to 2023-03-31 | Grant
National Institute of General Medical Sciences (Bethesda, US)
GRANT_NUMBER: SC3GM131986
Source: Self-asserted source
Rami Al-Horani via DimensionsWizard

Non-Heparin, Sulfated, Readily Synthesized, Allosteric Direct Factor XIa Inhibitors as Potentially Safe Anticoagulants

2012-07-01 to 2014-06-30 | Grant
American Heart Association (Dallas, US)
GRANT_NUMBER:

12POST10930004

Source: Self-asserted source
Rami Al-Horani via DimensionsWizard